Enrique A. Conterno - 07 Jun 2023 Form 4 Insider Report for FIBROGEN INC (FGEN)

Role
Chief Executive Officer, Director
Signature
/s/ Cecelia Monoarfa-Taime, Attorney-in-fact
Issuer symbol
FGEN
Transactions as of
07 Jun 2023
Net transactions value
-$151,583
Form type
4
Filing time
09 Jun 2023, 19:10:51 UTC
Previous filing
11 Apr 2023
Next filing
10 Jul 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FGEN Common Stock Sale $47,550 -2,791 -0.72% $17.04* 382,708 07 Jun 2023 Direct F1, F2
transaction FGEN Common Stock Sale $104,033 -6,106 -1.6% $17.04* 376,602 07 Jun 2023 Direct F1
holding FGEN Common Stock 27,800 07 Jun 2023 By Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I.
F2 Includes 2,500 shares acquired on May 15, 2023 through the Issuer's Employee Stock Purchase Plan.